Table 1: The demographic characteristic of the patients treated with brodalumab.

Patient

Age

Sex

PsoA

Duration of disease (years)

Nails Involvement

Palmo-plantar

Genitalia

Scalp

Previous biologic treatments

Comorbidities

1

28

M

no

10

no

Yes

yes

no

none

none

2

61

M

no

30

no

no

no

yes

none

hypercolesterolemia

3

50

M

No

3

Yes

Yes

No

no

none

none

4

22

M

No

2

 No

No

No

no

none

None

5

49

F

No

1

No

No

No

yes

none

Obesity, T2DM, Hypertension

6

66

M

no

15

no

yes

yes

yes

Ixekizumab

none